Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non Operating Income (2016 - 2023)

Historic Other Non Operating Income for Pharma-Bio Serv (PBSV) over the last 8 years, with Q3 2023 value amounting to $126985.0.

  • Pharma-Bio Serv's Other Non Operating Income rose 33654.6% to $126985.0 in Q3 2023 from the same period last year, while for Jul 2023 it was $628228.0, marking a year-over-year increase of 142666.3%. This contributed to the annual value of $13418.0 for FY2022, which is 9932.15% down from last year.
  • As of Q3 2023, Pharma-Bio Serv's Other Non Operating Income stood at $126985.0, which was up 33654.6% from $192616.0 recorded in Q2 2023.
  • In the past 5 years, Pharma-Bio Serv's Other Non Operating Income ranged from a high of $2.0 million in Q3 2021 and a low of -$53683.0 during Q3 2022
  • Its 4-year average for Other Non Operating Income is $194439.0, with a median of $4404.0 in 2022.
  • In the last 5 years, Pharma-Bio Serv's Other Non Operating Income plummeted by 10274.89% in 2022 and then surged by 3998861.79% in 2023.
  • Quarter analysis of 4 years shows Pharma-Bio Serv's Other Non Operating Income stood at $641.0 in 2020, then skyrocketed by 104.37% to $1310.0 in 2021, then soared by 4639.08% to $62082.0 in 2022, then surged by 104.54% to $126985.0 in 2023.
  • Its last three reported values are $126985.0 in Q3 2023, $192616.0 for Q2 2023, and $246545.0 during Q1 2023.